ERBB2 and breast cancer: Following this, numerous AI models have been created with the sole purpose of predicting the HER2 status through the analysis of H&E-stained slides [81,104,105], with some of them even being able to predict trastuzumab response in BC at an accuracy that may benefit clinical evaluations [106].